uz
Feedback
Introduction Modules | MW

Introduction Modules | MW

Kanalga Telegram’da o‘tish

Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2

Ko'proq ko'rsatish

📈 Telegram kanali Introduction Modules | MW analitikasi

Introduction Modules | MW (@introduction_modules) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 26 029 obunachidan iborat bo'lib, Tibbiyot toifasida 818-o'rinni va Misr mintaqasida 723-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 26 029 obunachiga ega bo‘ldi.

12 Iyun, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 54 ga, so‘nggi 24 soatda esa -9 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 3.64% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining N/A% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 0 marta ko‘riladi; birinchi sutkada odatda 0 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 0 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent module, general, microbiology, summary, بارا kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2

Yuqori yangilanish chastotasi (oxirgi ma’lumot 13 Iyun, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

26 029
Obunachilar
-924 soatlar
-37 kunlar
+5430 kunlar
Postlar arxiv
الحصة دي مكنش اترفعلها ريكورد

Metabolism 1.aac33.39 MB

V.d and factors affect distribution.aac51.94 MB

Bio-availability.aac29.22 MB

فارما حليم ريكوردات النظري

35 - Revision of Tut 4, General aspects of neoplasia 2 ( Malignant tumers) , Pathology.mp4 Quality : 🎬 480p

33 - Revision of Tut3 & CBL1 , General aspects of neoplasia 1 & locally malignant tumors , Pathology.mp4 Quality : 🎬 480p

29 - Revision of Tut 2, Repair, pathology.mp4 Quality : 🎬 480p

25 - Revision of L12 , General characters of neoplesia , pathology.mp4 Quality : 🎬 480p

24 - Revision of Tut1 part1 , Granuloma , Pathology.mp4 Quality : 🎬 480p

23 - Revision of SDL1 , Bacterial infection , Pathology.mp4 Quality : 🎬 480p

22 - Revision of L11, Thrombosis, Embolism, Hemorrhage and Shock, Pathology.mp4 Quality : 🎬 480p

20 - Revision of L 10, Ischemic, Infarction , Hyperemia and congestion, Pathology.mp4 Quality : 🎬 480p

19 - Revision of Tut1 part2 , Granuloma , Pathology.mp4 Quality : 🎬 480p

18 - Revision of L9 , Granuloma (Bilharziasis), Pathology.mp4 Quality : 🎬 480p

17 - Revision of L7,8 , Chronic inflammation & Granuloma (TB) , Pathology.mp4 Quality : 🎬 480p

11 - Revision of L6, Types of acute inflammation, pathology.mp4 Quality : 🎬 480p